Charles Huang (American businessman)
Charles Huang | |||
|---|---|---|---|
| |||
| Born | Wuhan, Hubei, China | ||
| Nationality | Chinese | ||
| Citizenship | China | ||
| Alma mater | Wuhan University (BA, 1988)
University of Strathclyde (MBA, 1989; PhD, 1994) | ||
| Occupation | Founder & Chairman of Pasaca Capital | ||
| Known for | Founding Pasaca Capital, Innova Medical Group, and Charles Huang Foundation | ||
Charles Huang (born 1964) is a Chinese-born American businessman, investor, and philanthropist.
Early life
Huang was born in Hubei, China in 1964. He received his BA from Wuhan University.[1]
Upon graduation, he received a scholarship from the British Council for International Students and enrolled at the University of Strathclyde in Scotland to study business administration. He received his MBA in 1989 and a PhD in marketing in 1994, both from the University of Strathclyde.[2] During his PhD studies, Huang came under the mentorship of Professor Stephen Young, a former head of the department of marketing at the university, and researched the globalization of Chinese enterprises.
Career
Early career in securities
Upon graduating in 1994, Huang began his professional career as a securities analyst at HSBC (then James Capel Asia) in Hong Kong, covering H-share and B-share companies across various industries. [3] He was among the first generation of Chinese equity analysts to work in Hong Kong. In 1996, he joined CLSA Asia Pacific as a senior analyst in China Research, covering China's automotive, transport, and infrastructure sectors.
Huang joined China Brilliance Group for a seven-year tenure and served as its finance director.
He was CFO of Compass Pacific from 2000 to 2004 and became its deputy chairman in 2002.
Pasaca Capital
In 2016, Huang founded Pasaca Capital, a private equity firm based in Los Angeles, California.[1]
Innova Medical Group
In March 2020, Huang founded Innova Medical Group, which would become the COVID test kit provider in the world.[4] Innova claims to have delivered over 1.5 billion test kits to more than 30 countries.
Innova's test kits were used in the UK government's Operation Moonshot, a mass-testing program intended to test millions of UK residents for COVID-19 every day.[5]
Philanthropy
Huang founded the Charles Huang Foundation with a mission to "bolster, enable, and inspire global development in education, health, and innovation."[6] Through the foundation, Huang has made substantial donations to his alma maters, including a £50m donation to the University of Strathclyde, "the biggest single donation to any Scottish university, and among the most generous made to any British university."[7][2]
References
- ↑ 1.0 1.1 admin (2016-05-08). "Executives | Pasaca Capital Inc". Retrieved 2021-10-28.
- ↑ 2.0 2.1 "Grateful ex-student donates £50m to Strathclyde University". BBC News. 2021-09-21. Retrieved 2021-10-28.
- ↑ "BIOGRAPHY OF CHINA & HONG KONG RESEARCH TEAM FOR BNP PARIBAS SECURITIES (ASIA)" (PDF). BNP Paribas.
{{cite web}}: CS1 maint: url-status (link) - ↑ "About | Innova Medical Group | Global Covid Antigen Tests". Innova Medical Group. 2020-12-09. Retrieved 2021-10-28.
- ↑ Gross, Anna; Bott, Ian (2020-11-04). "UK spends £1bn on Boris Johnson's rapid coronavirus testing 'moonshot'". Financial Times. Retrieved 2021-10-29.
- ↑ "Our Vision". Charles Huang Foundation. Retrieved 2021-10-28.
- ↑ "The Charles Huang Foundation Makes $70million USD Landmark Philanthropic Gift to The University of Strathclyde". Charles Huang Foundation. Retrieved 2021-10-29.
External links
This article "Charles Huang (American businessman)" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.